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Abstract
Bias due to unobserved confounding can seldom be ruled out with certainty when using non-
experimental data to draw inferences about causal e¤ects. The instrumental variable (IV) design
o¤ers under certain assumptions, the opportunity to tame confounding bias, without directly ob-
serving all confounders. The IV approach is very well developed in the context of linear regression
but also for certain generalized linear models with non-linear link function. However, IV methods
are not as well developed for censored survival outcomes. In this paper, the authors develop
the instrumental variable approach in a survival context, under an additive hazards model, and
they describe two simple strategies for estimating causal e¤ects for this context. The rst strategy
entails a straightforward two stage regression approach analogous to two stage least squares com-
monly used for IV estimation in linear models, whereby the tted value from a rst stage regression
of the exposure on the IV is entered in place of the exposure in the second stage hazard model
to recover the causal e¤ect in view. The second strategy is a so-called control function approach,
which entails adding as confounding control covariate to the additive hazards regression model for
the exposure e¤ect, the residual from a rst stage regression of the exposure on the IV. Formal
conditions are given justifying each strategy, and the methods are illustrated in a novel application
to a Mendelian randomization study of the causal association between diabetes status at start of
follow-up and mortality using data from the Health and Retirement Study. It is also shown that
analogous estimation strategies can also be used under a proportional hazards model specication
provided the outcome is rare over the entire follow-up period under consideration.
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Confounding bias remains to date a major potential source of bias in observational studies con-
ducted in epidemiology. In recent years, epidemiologists have slowly expanded their analytic
toolbox to account for unobserved confounding, by adopting the instrumental variable design, an
approach for analyzing non-experimental studies, historically favored by economists and other so-
cial scientists.1;2 The IV design entails selecting an observed pre-exposure variable which is known
to only be associated with the outcome to the extent that the latter is causally a¤ected by the
exposure of interest, and the IV is directly related to the exposure. Thus, the IV is selected such
that it does not directly a¤ect the outcome (known as the exclusion restriction), and, although
correlated with the exposure in view, it is independent of confounders of the exposure-outcome
relation. A valid IV may be hard to nd in practice, but when successfully selected to meet these
criteria, an IV can sometimes be used to account for unobserved confounding bias.1 4
Instrumental variable methods are particularly well developed in the context of linear models,4;5
and similar methods are likewise well developed for regression analysis with certain nonlinear link
functions (e.g. log, logit, probit).5 7 Right censored survival outcomes are of common occur-
rence in epidemiologic practice, and regression analysis on the hazard scale is typically used. The
Cox proportional hazards model is perhaps the most popular regression framework for survival
data,8 and recently, Aalens additive hazards model has also gained popularity as an alternative
framework.9 An important appeal of the additive hazards framework is that, unlike proportional
hazards models, the class of additive hazards models is closed under marginalization over regres-
sors. Specically, collapsing over a continuous regressor in an additive hazards model can under
fairly reasonable assumptions, produce a marginal additive hazards model. This property is known
not to generally hold for the Cox proportional hazards model, except perhaps for a disease that
remains rare over the follow-up period of the study. In this paper, the authors exploit the col-
lapsibility of additive hazards to develop two straightforward strategies for IV estimation with a
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censored survival outcome. The rst strategy entails a straightforward two stage regression ap-
proach analogous to two stage least squares commonly used for IV estimation in linear models.5
The current setting di¤ers from that of standard two stage least squares in that, here, the tted
value from the rst stage regression of the exposure on the IV is entered in place of the exposure
in a second stage additive hazards model, instead of a standard linear regression model to recover
the causal e¤ect in view. The second proposed strategy is a so-called control function approach,5
which entails adding to the additive hazards regression model for the exposure e¤ect, the residual
from a rst stage regression of the exposure on the IV also known as a control function. Formal
conditions are given justifying each strategy, and the methods are illustrated in a novel applica-
tion to a Mendelian randomization study of the causal association between diabetes diagnosis and
mortality using data from the Health and Retirement Study.10 Finally, it is shown that when the
disease outcome is rare, in the sense that its cumulative incidence remains low over the follow-up
period under consideration, then analogous two stage regression and control function strategies
may be used under a Cox proportional hazards model.
Two-stage regression approach
Suppose one has observed independent and identically distributed data on (T ; A; Z) for a sample
of size n; where A is an exposure of interest, Z is the candidate IV, T is the time to event outcome
and T  = min(T; Y ) with Y the potential censoring time. Unless stated otherwise, we assume that
Y is independent of (T;A) conditional on Z. To introduce the causal model of interest, suppose
that the e¤ect of the IV Z on the outcome T is unconfounded, however, we will suppose that
the e¤ect of A on T remains confounded whether one conditions on Z or not. Let U denote the
unobserved confounder of the e¤ect of A on T; so that conditioning on U recovers the causal e¤ect
of A on T . To further ground ideas, we will suppose the data are generated under the Aalen
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additive hazards model
h (tjA;U; Z) = b0 (t) + ba (t)A+ bu(U; t) (1)
where h (tjA;U; Z) is the hazard function of T evaluated at t; conditional on A;U and Z; and the
functions (b0 () ; ba () ; bu (; )) are unrestricted. The model states that conditional on U; the e¤ect
of A on T encoded on the additive hazards scale is linear in A for each t, however, the e¤ect size
ba (t) may vary with t: The model is quite exible in the unobserved confounder association with
the outcome bu (; ), which is allowed to remain unrestricted at each time point t and across time
points: In the Mendelian randomization study we will consider below, A represents diabetes status
measured at start of follow-up coded as a binary variable (1 if diabetic and 0 otherwise), T is
time to death, and Z is dened as a genetic risk score for diabetes; which combines several genetic
variants previously established to predict diabetes risk. The approach is described in additional
detail below. More generally, A could be continuous, such as say body mass index (BMI), in which
case the above Aalen model assumes linearity of the conditional hazards di¤erence at each t. The
null hypothesis of no causal e¤ect of A (BMI or diabetes status) on T (mortality) is encoded by
ba (t) = 0 for all t: An important sub-model to consider is the constant hazards di¤erence model
obtained by setting
ba (t) = ba (2)
where ba is an unknown constant. Crucially, the model assumes no interaction between A and
U . Collapsibility over U makes ba (t) interpretable as a marginal causal hazards di¤erence (upon
standardization with respect to the population distribution of U), which is an appealing feature
of the model since it would indeed be uncomfortable to come up with an e¤ect size that is only
interpretable conditional on the unobserved U . The baseline hazard function b0 (t) is a priori
unrestricted. Finally, the right hand side of equation (1) does not depend on Z; even though the
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left hand side of the equation conditions on Z; so that the model encodes explicitly the assumption
that Z and T are conditionally independent given (U;A); i.e. the exclusion restriction condition.11
In practice, additional pre-exposure covariates X (e.g. age, gender, education, ...etc) may be
observed, and one may wish to account for such covariates in an IV analysis. In order to ease the
presentation, we will rst describe the proposed methodology without covariates, so as to more
easily focus on key ideas, however, later, we will describe how the methods can be modied to
incorporate such covariates.
Until otherwise stated, suppose that A is continuous, e.g. body mass index (BMI). Then, in
addition to equation (1) ; one may specify a standard linear model for A :
A = c0 + czZ + ; where  is mean zero residual error independent of Z (3)
We do not further specify the distribution of , and we allow for U and  to be conditionally
associated given Z, i.e. COV (,U jZ) 6= 0; inducing confounding by U . Throughout, we will
assume that cz 6= 0 so that there is a non-null association between Z and A: However, cz may not
have a causal interpretation, in the event of unobserved confounding of the e¤ect of Z on A. We
will however assume that any unobserved common cause of Z and A must be independent of U:
Let M = m (Z) = E(AjZ) = c0 + czZ:
The proposed two-stage approach is based on the following result, which provides an analytic
expression for the conditional hazard model eh(tjZ), of T evaluated at t, conditional on Z; under
model restrictions (1) and (3) :
RESULT 1: Under assumptions (1) and (3) ; and assuming that U is independent of Z; one has
that
eh(tjZ) = eb0 (t) + ba (t)M (4)
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for eb0 (t) a baseline hazard function.
Result 1 states that under assumptions (1), (3) and the assumption of independence of U and
Z; the hazard function of T at t conditional on Z is linear in M = m(Z): Suppose for a moment
that, contrary to fact, M = E(AjZ) were observed, thus rendering model (4) a standard Aalen
additive hazards model with covariateM: Inference about B(t) =
eb0 (t) ; ba (t)T for such a model
has been well studied and can be obtained using the R package TIMEREG.12 Let B(t) denote
Aalens least squares estimator of B(t) under model (4) which we provide in the Appendix for
completeness and which can be computed using TIMEREG. The proposed two-stage approach
entails in the rst stage, estimating M with cM; the tted value of the ordinary least squares
regression of A on Z; i.e. cM = bc0 + bczZ; where (bc0;bcz) is the ordinary least squares estimator
of (c0; cz) : The second stage then involves obtaining Aalens least squares estimator bB(t) of
B(t); dened similarly to B(t); with cM substituted for M: Estimation under assumption (2) is
also easily accommodated in TIMEREG.12;13 However, some care is generally required to obtain
valid inferences about the regression parameter B(t); because one must acknowledge in computing
standard errors and condence intervals, the additional uncertainty due to the rst stage estimation
of M: Standard errors obtained in R will fail to appropriately account for this extra variability
and thus will tend to understate uncertainty. A simple remedy is to perform either the jackknife
or the nonparametric bootstrap, either of which will produce more accurate estimates of standard
errors.14 For completeness, we also provide in the Appendix, an analytic expression of a consistent
estimator of the corrected standard error of bB(t):
Occasionally, the rst stage OLS estimate (bc0;bcz) may be obtained from an independent sample
to that used for the second stage estimation of (4) : This type of IV design, known as a split IV
design,15 has become quite common in Mendelian randomization studies in which genetic variants
dene the IV, so that the rst stage regression may be obtained in a sample that only includes data
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on the genetic variants and the phenotype dening the exposure of interest, but no information
on the outcome. The approach then entails obtaining from an independent sample, an estimate
of the causal hazards di¤erence, by combining (bc0;bcz) with genotype information in the second
sample to construct cM; which is then used to t the hazard model. Note that information on
phenotype A need not be available in the second sample in which the outcome is available. Also,
the split sample IV design is known in linear models to confer robustness to the weak instrumental
variable problem, in that, in the event of a (nearly) null relation between the IV and the exposure
of interest, the approach is guaranteed to deliver an e¤ect estimate that is biased towards the
null.15 A similar robustness property is expected to hold for the above two-stage linear-additive
hazards regression analysis. An additional appeal of the split IV design is that, uncertainty in
the rst stage estimation can essentially be ignored, if as in the case in the empirical example
presented below, the sample size for the rst stage is considerably larger than that of the second
stage.
Control function approach
In this section, we will consider an alternative approach to two-stage regression for estimation.
Consider the sub-model of (1) which further species
bu(U; t) = 0 (t)  + "(t) (5)
where  is the residual error dened in (3) ; " (t) is a random error independent of (; Z), which
may not have mean zero, and the unknown function 0 (t) is a priori unrestricted. The model
makes explicit the dependence between  and U; encoded in a nonnull value of 0 (t) 6= 0, and
induces confounding bias: The residual error "(t) introduces additional variability to ensure that
the relation between U and  is not assumed deterministic, however, beside for independence
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with (; Z); the distribution of "(t) is otherwise unrestricted (up to certain regularity conditions
provided in the Appendix). Let h(tjA;Z) denote the observed hazard function of T given (A;Z);
evaluated at t: Then, we have the following result:
RESULT 2: Under assumptions (1), (3) and (5) one has that
h(tjA;Z) = b0 (t) + ba (t)A+ 0 (t)  (6)
for b0 (t) a baseline hazard function:
Result 2 provides an explicit parametrization of the hazard function of T conditional on A and
Z; under assumptions (1), (3) and (5) : This result shows that an appropriate model specication of
h(tjA;Z) is essentially obtained upon replacing bu(U; t) with 0 (t) , and by allowing the baseline
hazard function b0 (t) to di¤er from b0 (t) : Intuitively, the residual  captures any variation due
to unobserved correlates of A; not accounted for in M; that may also be associated with T; and
thus serves as a proxy measure of unobserved confounding. For this reason, "0 (t) " is referred
to as a control function, akin to the control function sometimes used in IV estimation of linear
and nonlinear models.5 For estimation, we propose to use b = A   cM as an estimate of the
unobserved residual  which we use to t an additive hazards model, with regressors

A; b
under (8) : Such an additive hazards model can be estimated using the methods and statistical
software described in the previous section and the nonparametric bootstrap equally applies as an
approach to appropriately account for uncertainty due to in-sample estimation of b. In situations
where a split sample IV design is adopted, the rst sample estimation can essentially be ignored,
when the size of the sample is much greater than that used in the second stage. Furthermore, as in
the previous section, the rst stage sample does not need to include outcome data, however, unlike
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in the previous section, the second stage sample must have data collected on the IV, the exposure
and the outcome for all observations. The model is easily modied to incorporate heterogeneity
with respect to Z in the degree of confounding bias, by simply extending model (5) with the
additional covariate Z; such that
bu(U; t) = (0 (t) + 1 (t)Z)  + "(t);
where " (t) is a random error independent of (; Z): This in turn yields the conditional hazard
model
h(tjA;Z) = b0 (t) + ba (t)A+ 0 (t)  + 1 (t) Z
such that the null hypothesis of no confounding bias, now corresponds to the joint null hypothesis
0 (t) = 1 (t) = 0 for all t:
Finally, one may note that it su¢ ces for the control function approach, that censoring is
independent of T conditional on (A;Z); a somewhat weaker independent censoring assumption
than needed for the stage regression approach.
Binary exposure
The control function approach can also be used in the context of a binary or more general dis-
crete exposure. In the simple case of a binary exposure, the methods described in the previ-
ous section apply upon estimating M with an appropriate regression model for binary data, e.g.
logitM =logitm (Z) =logitPr(A = 1jZ) = c0 + czZ: The approach can be motivated under a mod-
ied set of assumptions to account for the binary nature of the treatment. Specically, suppose
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that
bu(U; t) = E fbu(U; t)jA;Zg+ "(t) (7)
where "(t) is an independent error, and both A and Z are binary. The assumption is best under-
stood if bu(U; t) = bu(t)U is linear in U; in which case the assumption amounts to a location shift
model for the density of U conditional on A and Z; i.e. (A;Z) are associated with U only on the
mean scale. The assumption is certain to hold say if U were normal with constant variance, but
the model also allows for a more exible distribution. Then, we have the following result.
RESULT 3: Assuming Z is a valid binary IV and both assumptions (1) and (5) hold, one has that
h(tjA;Z) = eb0 (t) + ba (t)A+ f0 (t) + 1 (t)Zg; (8)
for eb0 (t) a baseline hazard function, and
 = A  Pr(A = 1jZ):
The model of equation (8) is again an Aalen additive hazards model which can be estimated
in a manner analogous to the control function approach described in the previous section for a
continuous exposure. Although the result assumes binary Z; we may nonetheless use model (8)
with continuous Z, under an additional assumption that E fbu(U; s)jA;Zg is linear in Z:
Sensitivity analysis
We briey describe a sensitivity analysis technique that may be used to assess the extent to which a
violation of the exclusion restriction might impact inference. The approach is motivated by noting
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that a violation of the assumption can be encoded by modifying the Aalen model (1) as followed
h (tjA;U; Z) = b0 (t) + ba (t)A+ bz (t)Z + bu(U; t)
whereby bz (t) encodes the causal e¤ect of Z on T on the additive hazards scale, so that bz (t) = 0 for
all t recovers model (1) ; while bz (t) 6= 0 for some t implies violation of the exclusion restriction.
The function bz (t) cannot be identied from the model, and entails a sensitivity parameter. To
x ideas, it is convenient to take bz (t)=bz independent of t. A sensitivity analysis is then obtained
by setting bz to a specic value bz 6= 0 and to obtain inferences under the assumed departure from
the exclusion restriction. This can be achieved by simply including the term "bzZ" as a known
o¤set to the additive hazards model which may then be estimated via either two stage regression
or the control function approach. A sensitivity analysis is obtained by varying the assumed value
bz and subsequently obtaining inferences about the e¤ect of A for each assumed value.
Covariate Adjustment
Suppose that one has collected a vector of pre-exposure confounders X of the e¤ects of (Z;A)
on Y: In this section, we show how the proposed IV methods are easily modied to incorporate
X. Formal justication for the approach is relegated to the Appendix. The rst stage regression
model can be formulated as followed to make explicit the dependence on X,
A = c0 + czZ + c
T
xX +  (9)
where cx encodes the regression association of X with A conditional on Z, and  is assumed to be
independent of Z given X: In the Appendix, we show that under certain assumptions, the second
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stage regression obtained in Result 1 can be modied to account for X using the more general
Aalen model
eh(tjZ;X) = eb0 (t) + ba (t)M + bTx (t)X (10)
with M = m(X;Z) = c0 + czZ + c
T
xX and b
T
x (t) encoding the e¤ect of X on the hazard of
T at t; conditional on M on the additive hazards scale. Two stage estimation using the above
regression models can be implemented in R using the same procedure as previously described
without additional di¢ culty. The control function approach can also be modied along the same
lines, by tting the regression model
h(tjA;Z) = b0 (t) + ba (t)A+ bTx (t)X + 0 (t)  (11)
instead of (8) : Formal justication for this modication can be obtained for continuous A by
replacing assumption (5) with
bu(U;X; t) =  (t)  + b
T
x (t)X + "(t) (12)
where " (t) is a random error independent of (; Z;X): We briey note that previous state as-
sumptions about censoring will need to be modied by also conditioning on X.
IV for Cox proportional hazards model
Suppose that the underlying failure time outcome follows the proportional hazards model
h (tjA;U; Z) = h0 (t) exp (baA+ bu(U; t)) (13)
where ba is the log-hazards ratio encoding the e¤ect of exposure, and bu(U; t) denotes the e¤ect of an
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unmeasured confounder U at time t, so that COV (,U jZ) 6= 0; where  is given by the exposure
model (3) ; and Z is independent of U: Equation (13) also encodes the exclusion restriction by
dening the left hand-side conditional on (A;Z; U), while the right-hand side does not depend on
Z: In the following, we focus on the fairly common setting, of a rare outcome, which we encode by
near unity conditional survival curve throughout follow-up:
S(tjA;U; Z) = P (T  tjA;U; Z)
 1
for all t during follow-up. Let f (T jA;U; Z) denote the density of T given (A;U; Z) ; and recall
that the conditional hazard function is dened as h (tjA;U; Z) = f (tjA;U; Z) =S(tjA;U; Z). Then,
we have that:
f (tjA;U; Z) = h (tjA;U; Z)S(tjA;U; Z)
 h (tjA;U; Z)
Likewise, by the rare disease assumption,
f (tjZ) = E [f (tjA;U; Z) jZ]
= h (tjZ)S(tjZ)
 h (tjZ)
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therefore under the exposure model (3) ; one obtains:
h (tjZ)  E [h (tjA;U; Z) jZ]
= E [h0 (t) exp (baA+ bu (U; t)) jZ]
= E [h0 (t) exp (baM + ba + bu (U; t)) jZ] by equation (3)
= h0 (t) exp (baM) by independence of (U;) with Z: (14)
where h0 (t) = E [exp (ba + bu (U; t))]h0 (t). The above derivation formally justies the use of
two stage regression analysis, analogous to the two stage procedure previously described for the
Aalen model, whereby the tted value cM obtained via standard OLS; is used as a regressor in
place ofM in the standard Cox proportional hazards regression dened with equation (14) ; which
can then be estimated via standard maximum partial likelihood. A similar argument provides
justication for the use of a control function approach for Cox regression under rare disease. In
this vein, suppose that bu(U; t) follows equation (5) ; so that
h (tjA;Z)  E [h (tjA;U; Z) jA;Z]
= E [h0 (t) exp (baA+ bu (U; t)) jA;Z]
= E [h0 (t) exp (baA+  (t)  + "(t)) jA;Z]
= h0 (t) exp (baA+  (t) )
where h0 (t) = h0 (t)E [exp ("(t))] :One immediately recovers a standard Cox proportional hazards
model by letting  (t) = ; so that (; ba) can be estimated via standard maximum partial likelihood,
upon substituting b for : For inference, we recommend either the jackknife or the nonparametric
bootstrap. It is also fairly straightforward to incorporate covariate adjustment in an analogous
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manner to the additive hazards setting, details are omitted.
Intuition for the above results for Cox regression can be gained upon noting that a Cox regres-
sion analysis is essentially a loglinear regression for the risk of the outcome performed repeatedly
over the follow-up period, among persons that remain at risk for the outcome. For a rare outcome,
the joint distribution of the instrumental variable, the unobserved confounder and the exposure in
view, is nearly stable across risk sets, so that the IV assumptions are ensured to hold within each
risk set, and the exclusion restriction is satised within each risk set. The framework then essen-
tially reduces to IV for loglinear regression analysis, for which two stage regression has previously
been shown to apply under assumptions analogous to those considered here.16
Empirical illustration.
The prevalence of type 2 diabetes mellitus (T2DM) is increasing across all age groups in the
United States possibly as a consequence of the obesity epidemic.17;18 In addition, no decline has
been observed in the excess mortality among persons su¤ering from T2DM relative to persons
without T2DM.19 Obtaining an unbiased estimate of the mortality risk associated with T2DM is
key to predicting the future health burden in the population and to evaluate the e¤ectiveness of
possible public health interventions.
In order to illustrate the proposed instrumental variable approach for survival analysis, we used
data from the Health and Retirement Survey (HRS), a public survey with repeated assessments
every 2 years initiated in 1992, to investigate the mortality risk associated with T2DM being instru-
mented by externally validated, genetic predictors of T2DM. HRS is a well-documented nationally
representative sample of individuals 50 years of age or older and their spouses.10 Genotype data was
collected on a subset of HRS respondents in 2006 and 2008. Genotyping was completed on the Illu-
mina Omni-2.5 chip platform and imputed using the 1000G phase 1 reference panel and led with
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the Database for Genotypes and Phenotypes (dbGaP, study accession number: phs000428.v1.p1)
in April 2012. Exact information on the process performed for quality control is available via
HRS and dbGaP21.20 From the 12,123 HRS participants for whom genotype data was available,
we restricted the sample to 8,446 Non-Hispanic Whites with valid self-reported diabetes status at
baseline. For deaths occurring between 1998-2008 the date of death was conrmed through the
National Death Index. Mortality status for 2008-2010 was obtained by interviewing surviving rela-
tives. Follow-up was determined as years since sampling of DNA (2006 or 2008 respectively). The
current analysis was exempt by the Institutional Review Board at the Harvard School of Public
Health.
We used the control function approach discussed previously to estimate the relationship between
diabetes status (coded 1 for diabetic and 0 otherwise) on Mortality. As genetic instrument we
used 39 independent single nucleotide polymorphisms previously established to be signicantly
associated with T2DM.21 In addition we created a polygenic risk score calculated on the basis of
these 39 established genetic variants and their external e¤ect size based on the meta-analysis
of 34,840 T2DM cases and 114,981 controls from Morris et al.21 The polygenic risk score was
calculated by multiplying each log odds ratio coe¢ cient by the corresponding number of risk
alleles and summing across the products.
For comparison, we rst performed an observational analysis, which entailed tting a standard
Aalen additive hazards model for T2DM. Next, we implemented the proposed control function
instrumental variable approach, which is appropriate for binary endogenous variable. In addition
to the rst stage residual, we also adjusted for possible e¤ect heterogeneity of the degree of selection
bias by including an interaction between the rst stage residual and the rst stage risk score. All
regression models further adjusted for: age, sex and the top four genomewide principal components
to account for possible population stratication. Inferences were based on 5000 nonparametric
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bootstrap samples.
Participants were on average 68.5 years old (Standard Deviation (SD): 10.4) at baseline and
1,891 self-reported diabetics (22.4%). The average follow-up time was 4.10 years (SD = 1.10). In
total we observed 644 deaths over 34035 person-years. The 39 SNPs jointly included in a rst stage
logistic regression model to predict diabetes status explained 3.4 % of the variation in diabetes in
the study sample (Nagelkerke R2).
Table 1 shows results from both observational and IV analyses. In the observational analysis,
being diabetic was associated with an increase in the hazard rate of beta=0.03 (95%-Condence
Interval (95%-CI): 0.025 0.035) per person-year. This means approximately 3 additional deaths
occured for each year of follow-up for every hundred diabetic persons, than for every hundred
diabetic-free persons. The genetic IV approach produced a notably larger e¤ect associated with
T2DM, with a T2DM increase in the mortality rate of beta = 0.08 (95%CI: 0.075 0.090) per
person-year, nearly three times the rate estimated by the observational additive hazards model.
We obtained further evidence of signicant negative confounding bias reected by an association
between the rst stage residual and mortality rate, beta=-0.023 (95%CI:-0.028,-0.017), as well as
marginal evidence of confounding bias heterogeneity beta=-0.024 (95%CI:-0.052,0.001).
Using the external genetic risk score as a single IV gave essentially the same results, which are
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not reported.
Closing remarks
In this paper, the authors describe an instrumental variable framework of inference about causal
e¤ects of a continuous or binary exposure on a right censored failure time under an additive hazards
regression model. Two strategies for estimation are described, a two stage regression approach for
continuous exposure, similar to two stage least squares commonly used in linear regression IV
settings, and a control function approach that equally applies for binary and continuous exposure.
A notable distinction from the classical linear regression setting is that, in the current context
unlike in the latter, the rst stage regression model for the exposure must be correctly specied
in order for the proposed methods to generally remain valid. An important exception holds for
the two stage regression approach under the null hypothesis of no causal e¤ect of A; in which case
the rst stage regression can be mis-specied without altering the nominal type 1 error rate of the
corresponding test statistic. A variety of extensions of the methods are also discussed, including a
simple strategy for covariate adjustment, and a sensitivity analysis approach for assessing the extent
to which a violation of the exclusion restriction assumption could impact inference. In certain
settings, both the exposure of interest and the instrumental variable may be time-updated, in which
case, the methods described above may not directly apply. Instrumental variable estimation of the
joint e¤ects of time-updated exposures present several challenges beyond the scope of the current
manuscript, and to the best of our knowledge, methods are currently not available to address these
challenges for either the additive hazards model, or the Cox proportional hazards model studied
herein, although IV methods for joint e¤ects are available under alternative modeling assumptions,
such as the semiparametric accelerated failure time model.22 However, available methods for the
semiparametric accelerated failure time model, whether for point or time varying exposures, may be
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computationally challenging in practice, because they sometimes require censoring a set of subjects
(dened according to the causal parameter) whose event time was observed for unbiasedness.
In the point exposure scenario, alternative IV methods have been proposed under a structural
proportional hazards model,23;24 which do not require articial censoring and which do not rely
on a rare disease assumption, however, in contrast with the methods we have developed herein
for a proportional hazards model, earlier proposals were limited to either binary instrumental
variable or binary exposure variable.23;24 In a more recent proposal, MacKenzie and colleagues
use an instrumental variable to estimate a Cox proportional hazards model subject to additive
unobserved confounding.25 Specically, they specify a so-called additive multiplicative hazards
model,26;27
h (tjA;U; Z) = h0 (t) exp (baA) + bu(U; t)) (15)
with the key restriction
E fbu(U; t)jT (a)  tg = 0 (16)
where T (a) is the potential outcome of T under treatment a: The model combines features of
models (1) and (13) since it incorporates both an additive e¤ect of U and a multiplicative e¤ect of
A: The restriction (16) ensures that the marginal hazard model of T (a) follows a Cox proportional
hazards model. The authors note that this restriction is generally satised if bu(U; t) can be written
d(t)U + ln mgfU fd(t)g ; where mgfU stands for the moment generating function of U: Under such
unobserved confounding, the authors show that a valid IV can be used to recover a consistent
estimator of ba: Although interesting this model may be more contrived than initially meets the
eye, because supposing that U were observed, assumptions (15) and (16) imply that the conditional
hazard function of T (a) at time t given U does not only depend on the value of U , but further
depends on the underlying distribution of the unobserved confounder. For instance, if U were
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normally distributed N(; 2U); we would have ln mgfU fd(t)g = d(t) + 2Ud(t)2=2. The model
would then imply that the density of T conditional on (A;U) is made to depend explicitly on the
parameters (; 2U) of the density of the covariate U: Such a parametrization is nonstandard and
somewhat articial in the sense that it would not naturally be entertained by an analyst if U were
in fact observed.
Finally, the control function approach described in this paper may also be seen as an extension
of the two stage residual inclusion (2SRI) approach of Terza et al.28 In order to ease a comparison
between the two methods, it is helpful to restate the key assumption underlying 2SRI within our
context using our notation. This is easiest achieved by simply replacing equation (5) with the more
restrictive model:
bu(U; t) = 0 (t)  (17)
obtained by setting "(t)  0 for all t; thus essentially assuming the relationship between U and 
is deterministic. This assumption may be unrealistic in most health related applications, since it
essentially rules out the existence of any other (unobserved) cause of A, that like Z may not be
directly related to the outcome, a possibility that cannot generally be ruled out with certainty. By
allowing for "(t) in equation (5) avoids this type of restriction. It is also notable that assumption
(17) may be overly restrictive for binary (or discrete) A; since the distribution of the residual 
is completely determined by the mean M(Z) of A, and therefore the IV assumption that Z is
independent of U is not compatible with the model. In this paper, we have provided an alternative
formulation of the control function approach for binary A, which circumvents this di¢ culty.
Acknowledgement 1 Eric Tchetgen Tchetgens work is funded by NIH grant R01AI104459.
Torben Martinussens work is part of the Dynamical Systems Interdisciplinary Network, University
of Copenhagen.
21 Hosted by The Berkeley Electronic Press
APPENDIX
Aalens least squares estimator: Consider the Aalen additive hazards model:
h (tjC) = B0T (s)C
with C a vector of covariates with rst entry equal to 1; to encode the baseline hazard function.
Let R(t) denote the at risk process at time t: The least squares estimator of B0 (t) due to Aalen
can be written:
bB0 (t) = (X
i
Ri(t)CiC
T
i
) 1X
i
CidNi(t)
where G 1 denotes the inverse of the matrix G; and dNi(t) is the counting process associated with
Ti; at time t:
A consistent estimator of the asymptotic variance:We use notation V = c0 + czZ and let M(t) be
the martingale with respect to the ltration where V is also observed. Let also c = (c0; cz), we
then have n1=2(c^  c) = n 1=2Pi ci + op (1), where the cis are zero-mean iid terms.
Let V^i = c^(1; Zi)T and V^ (t) be the n  2-matrix with ith row (Ri(t); Ri(t)V^i). The estimator
of B(t) = ( ~B0(t); Ba(t))T is therefore
B^(t) =
Z t
0
fV^ (t)T V^ (t)g 1V^ (t)TdN(t);
where N(t) is the vector counting processes. We have
Ri(t)V^i = Ri(t) Vi +Ri(t)(c^  c)(1; Zi)T ;
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and
n 1V^ (t)T V^ (t); n 1V (t)TV (t)
are therefore asymptotically equivalent since c^ is a consistent estimator of c. Throughout, we freely
assume without formally stating the necessary regularity conditions hold to establish asymptotic
stochastic convergence results.29 Then, we can further write
V^ (t)TdN(t) = V (t)TdN(t) + f0; (c^  c)
X
i
Ri(t)(1; Zi)
TdNi(t)gT :
But then
n1=2B^(t) =
Z t
0
fn 1V^ (t)T V^ (t)g 1n 1=2V^ (t)TdN(t)
=
Z t
0
fn 1V (t)TV (t)g 1n 1=2V (t)TdN(t)
+
Z t
0
fn 1V (t)TV (t)g 1f0; n1=2(c^  c)n 1
X
i
Ri(t)(1; Zi)
TdNi(t)gT ;
and
Z t
0
fn 1V (t)TV (t)g 1n 1=2V (t)TdN(t) = n1=2B(t) +
Z t
0
fn 1V (t)TV (t)g 1n 1=2V (t)TdM(t):
Hence,
n1=2fB^(t) B(t)g =
Z t
0
fn 1V (t)TV (t)g 1n 1=2V (t)TdM(t)
+
Z t
0
fn 1V (t)TV (t)g 1f0; n1=2(c^  c)n 1
X
i
Ri(t)(1; Zi)
TdNi(t)gT
+ oP (1):
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This gives us that
n1=2fB^(t) B(t)g = n 1=2
X
i
Bi (t);
where the Bi (t) are iid zero-mean processes that can be estimated by
^Bi (t) =
Z t
0
fn 1V^ (s)T V^ (s)g 1Yi(s)(1; V^i)TdM^i(s)
+
Z t
0
fn 1V^ (t)T V^ (t)g 1f0; ^cin 1
X
i
Ri(t)(1; Zi)
TdNi(t)gT :
with dcMi(t) = dNi(t) Ri(t)(1; V^i)dB^(t) and
^ci = fn 1(1; Zi)T (1; Zi)g 1(1; Zi)TAi:
Hence the variance of B^(t) is consistently estimated by
P
i ^
B
i (t)f^Bi (t)gT . We can likewise construct
uniform condence bands and do testing investigating for instance the hypothesis H0 : ba(t) = ba.
The rst term of ^Bi (t) is the usual martingale term pretending that c is known while the second
term gives the needed extra variation due to that c is estimated.
Proof of Result 1: We consider a more general model which allows for covariates X: In this vein,
suppose that conditional on (U;X;Z) ; the hazard function of T follows the semiparametric Aalen
model
h (tjA;U;X;Z) = b0 (s) + ba (s)A+ bx;u(X;U; s)
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The corresponding survival function is given by
S (tjA;U;X;Z) = exp

 
Z t
0
[b0 (s) + ba (s)A+ bx;u(X;U; s)] ds

= exp

 
Z t
0
b0 (s) + ba (s)Mds

 exp

 
Z t
0
ba (s)  + bx;u(X;U; s)ds

which induces the following survival function at time t conditional on (X;Z) upon marginalization
with respect to (A;U):
S (tjX;Z) = E [S (tjA;U;X;Z) jX;Z]
= exp

 
Z t
0
[b0 (s) + ba (s)M ] ds

 E

exp

 
Z t
0
[ba (s)  + bx;u(X;U; s)] ds

jX;Z

= exp

 
Z t
0
[b0 (s) + ba (s)M ] ds+Q(t;X)

where
Q(t;X) = logE

exp

 
Z t
0
[ba (s)  + bx;u(X;U; s)] ds

jX;Z

= logE

exp

 
Z t
0
[ba (s)  + bx;u(X;U; s)] ds

jX

In the absence of covariates, one recovers the result given in the text, where
eb0 (t) = b0 (t)  @Q(t)
@t
= b0 (t) 
@ logE
h
exp
n
  R t
0
[ba (s)  + bx;u(U; s)] ds
oi
@t
More generally, in the presence of covariates, one obtains the additive hazard function:
eh(tjZ;X) = b0 (t) + ba (t)M   @ logE
h
exp
n
  R t
0
[ba (s)  + bx;u(U; s)] ds
o
jX
i
@t
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which reduces to equation (10) under linear specication of the above function,i.e.
b0 (t) 
@ logE
h
exp
n
  R t
0
[ba (s)  + bx;u(U; s)] ds
o
jX
i
@t
= eb0 (t) + bTx (t)X
Proof of Result 2: To allow for covariates, suppose the following Aalen additive hazards model
holds:
h (tjA;U; Z) = b0 (t) + ba (t)A+ bu(U; t)
and further assume (9) and (12) hold, then:
h (tjA;U;X;Z) = b0 (s) + ba (s)A+ bx;u(X;U; s)
= b0 (s) + ba (s)A+  (t)  + b
T
x (t)X + "(t)
The corresponding survival function is then given by
S (tjA;U;X;Z) = exp

 
Z t
0
h
b0 (s) + ba (s)A+  (s)  + b
T
x (s)X + "(s)
i
ds

= exp

 
Z t
0
h
b0 (s) + ba (s)A+  (s)  + b
T
x (s)X
i
ds

 exp

 
Z t
0
"(s)ds

This in turn induces the conditional survival curve given (A;X;Z)
S (tjA;X;Z) = exp

 
Z t
0
h
b0 (s) + ba (s)A+  (s)  + b
T
x (s)X
i
ds

 E

exp

 
Z t
0
"(s)ds

= exp

 
Z t
0
h
b0 (s) + ba (s)A+  (s)  + b
T
x (s)X
i
ds+ logE

exp

 
Z t
0
"(s)ds

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with corresponding hazard function
b0 (t) + ba (t)A+  (t)  + b
T
x (t)X
where
b0 (t) = b0 (t) 
@ logE
h
exp
n
  R t
0
"(s)ds
oi
@t
Proof of Result 3: Under assumptions (1) and (5) one has that
S (tjA;U;X;Z) = exp

 
Z t
0
[b0 (s) + ba (s)A+ E fbu(U; s)jA;Zg+ "(s)] ds

= exp

 
Z t
0
[b0 (s) + ba (s)A+ E fbu(U; s)jA;Zg   E fbu(U; s)jZg] ds

exp

 
Z t
0
("(s)  E fbu(U; s)jZg) ds

= exp

 
Z t
0
[b0 (s) + ba (s)A+ (0 (s) + 1 (s)Z) (A m(Z))] ds

exp

 
Z t
0
("(s)  E fbu(U; s)g) ds

where
0 (s) = E fbu(U; s)jA = 1; Z = 0g   E fbu(U; s)jA = 0; Z = 0g
1 (s) = E fbu(U; s)jA = 1; Z = 1g   E fbu(U; s)jA = 0; Z = 1g
  E fbu(U; s)jA = 1; Z = 0g+ E fbu(U; s)jA = 0; Z = 0g
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and we use the fact that for binary A and Z;
E fbu(U; s)jA;Zg = [E fbu(U; s)jA = 1; Zg   E fbu(U; s)j0; Zg]A
+ E fbu(U; s)j0; Zg
= fE fbu(U; s)jA = 1; Z = 1g   E fbu(U; s)j0; Z = 1g
 E fbu(U; s)jA = 1; Z = 0g+ E fbu(U; s)j0; Z = 0ggZA
+ E fbu(U; s)jA = 1; Z = 0g   E fbu(U; s)j0; Z = 0gA
+ [E fbu(U; s)j0; Z = 1g   E fbu(U; s)j0; Z = 0g]Z
+ E fbu(U; s)j0; Z = 0g
and
E fbu(U; s)jZg = E fbu(U; s)g
by the independence property of the IV with U: We may conclude that
S (tjA;X;Z) = E fS (tjA;U;X;Z) jA;X;Zg
= exp

 
Z t
0
[b0 (s) + ba (s)A+ (0 (s) + 1 (s)Z) (A m(Z))] ds

E

exp

 
Z t
0
("(s)  E fbu(U; s)g) ds

= exp

 
Z t
0
heb0 (t) + ba (s)A+ (0 (s) + 1 (s)Z) i ds
with
eb0 (t) = b0 (t)  @ logE
h
exp
n
  R t
0
["(s)  E fbu(U; s)g] ds
oi
@t
proving the result.
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